A review of rilpivirine and elvitegravir resistance features and implications for treatment sequencing.

HIV clinician / Delta Region AIDS Education & Training Center

Volumn 24, Issue 4, 2012, Pages 12-15

  Bourgeois, Amber ^a   Womack, Samantha ^a   Newsom, Dan ^a   Caldwell, David ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ELVITEGRAVIR; INTEGRASE INHIBITOR; NITRILE; PYRIMIDINE DERIVATIVE; QUINOLONE DERIVATIVE; RILPIVIRINE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ANTIVIRAL RESISTANCE; ARTICLE; DRUG ADMINISTRATION; DRUG COMBINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION;

DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, VIRAL; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV INTEGRASE INHIBITORS; HUMANS; NITRILES; PYRIMIDINES; QUINOLONES; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 84872043600     PISSN: 1551885X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)